FemiCore Reviews: An Ingredient-by-Ingredient Look at the Bladder Supplement

Most FemiCore reviews follow the same script: a list of nine ingredients, a paragraph about the “urinary microbiome”, a pricing table and a five-star verdict. What they do not do is ask the question a supplement site should ask: for each ingredient, what human evidence exists, at what dose, and does the bottle contain that dose? This FemiCore review answers that, ingredient by ingredient, and then works out whether the product is worth the money for the women it is aimed at.

FemiCore is a once-daily capsule marketed to women with bladder leaks, sudden urges and night-time bathroom trips. It is sold only through the official website, where orders are handled by the retailer BuyGoods, and it comes with a 60-day money-back guarantee. We have no relationship with the manufacturer. Links on this page are affiliate links, which means we may earn a commission if you buy, and that commission does not change the grade below.

What FemiCore is

Product type	Dietary supplement, capsules
Target	Women with bladder leaks, urgency, frequent or night-time urination
Formula	9 ingredients in one proprietary blend: 4 botanicals + 5 Lactobacillus strains
Dose	1 capsule each morning with water
Bottle	30 capsules, 30-day supply
Claims	Non-GMO, no stimulants, made in a GMP-certified, FDA-registered US facility
Price	$49 to $79 per bottle depending on package
Guarantee	60 days, all bottles returned with packing slip
Sold by	Official website only (retailer: BuyGoods)

The product’s pitch rests on a shift in how urologists think about the bladder. Until about 2012, the bladder was taught to be sterile. Then researchers at Loyola University in Chicago used DNA sequencing and expanded culture techniques on urine collected directly from the bladder and found a resident bacterial community in healthy women (Wolfe et al., 2012). FemiCore’s argument is that if the bladder has a microbiome, and that microbiome looks different in women with urgency, then feeding the bladder the “right” bacteria should help.

That is a reasonable hypothesis. The rest of this review is about how far the ingredients get towards proving it.

The bladder microbiome: what the research actually shows

Two Loyola papers do most of the scientific lifting for FemiCore, so it is worth being precise about what they found.

The 2012 study established that bacteria live in the bladders of women without symptoms, and that standard urine culture misses most of them (Wolfe et al., 2012). The 2014 follow-up compared urine from women with urgency urinary incontinence against women without it (Pearce et al., 2014). The incontinence group had a more diverse bladder microbiome, with a lower proportion of Lactobacillus and a higher proportion of Gardnerella and other organisms. Women whose bladders were dominated by Lactobacillus, and particularly by L. crispatus, were more often in the symptom-free group.

Three things follow from this:

1. The association is real. A low-Lactobacillus bladder is linked to urgency incontinence in a well-conducted study.
2. Association is not cause. Nobody has yet shown that adding Lactobacillus to the bladder reduces urgency. It is possible that urgency changes the microbiome rather than the other way round, or that both are caused by something else, such as oestrogen decline after menopause.
3. The route matters. The bacteria in the 2014 study were in the bladder. A capsule is swallowed. For an oral probiotic to influence the bladder it has to survive the stomach, colonise the gut, and from there reach the urogenital tract. That is plausible for Lactobacillus species, which do travel from the gut to the vagina, but it is an extra step that the Loyola research did not examine.

So the premise earns a B for plausibility. The question is whether the ingredients, at the doses in the bottle, can act on it.

Ingredient-by-ingredient evidence grades

We grade each ingredient on the human research behind it for the purpose it is included in this product, using the same A to D scale as every article on this site. Because FemiCore does not disclose amounts, no ingredient can score above B, and most score lower.

Lactobacillus crispatus

Grade B (Moderate). This is the strain FemiCore’s marketing leans on hardest, and with some justification. L. crispatus is the dominant species in the vaginal and urinary microbiome of most women without symptoms, and the Loyola data linked its presence to the absence of urgency.

The best clinical evidence is a randomised, placebo-controlled phase 2 trial in 100 women with recurrent urinary tract infections, who received an L. crispatus strain (CTV-05) or placebo for ten weeks. Recurrence occurred in 15 percent of the probiotic group against 27 percent of the placebo group, and women who became colonised with the strain had the largest reduction (Stapleton et al., 2011).

Two caveats cut the grade from A to B. First, that trial used an intravaginal suppository, not an oral capsule. Second, the outcome was infection recurrence, not leaks or urgency. The strain in FemiCore is not identified beyond the species name, and oral L. crispatus products have far less data than the vaginal ones.

Cranberry extract

Grade B (Moderate) for urinary tract infection prevention; D for incontinence. Cranberry is the most studied botanical in urinary health. The 2023 Cochrane review, covering 50 trials and more than 8,800 participants, concluded that cranberry products reduce the risk of symptomatic urinary tract infections in women with recurrent infections, in children and in people after bladder interventions (Williams et al., 2023). That is a notable reversal from the 2012 review, which had found insufficient evidence.

The active compounds are A-type proanthocyanidins (PACs), which reduce the ability of E. coli to adhere to the bladder wall. Trials that worked typically used extracts standardised to around 36 mg of PACs per day. FemiCore does not state its cranberry dose or PAC content, so there is no way to know whether it reaches that level.

More importantly for the product’s actual claim: cranberry has not been shown to reduce leaks or urgency in women without infection. Its inclusion makes sense for urinary tract comfort, which is how FemiCore phrases it, not for continence.

Bearberry (Uva Ursi) leaf

Grade C (Limited). Bearberry leaf contains arbutin, which the body converts to hydroquinone, a compound with antibacterial activity in the urinary tract. It has been used for centuries for urinary complaints and is approved in several European pharmacopoeias for short-term use.

The one modern trial of note is the ATAFUTI study, a factorial randomised trial in UK general practice that tested uva ursi extract against placebo in women with uncomplicated urinary tract infection symptoms. It found no significant effect on symptom duration (Afshar et al., 2018). For the purpose FemiCore uses it, which is daily cleansing support rather than treating infection, there are no trials at all.

There is also a safety point. European monographs recommend bearberry for no more than one week at a time and no more than five times a year, because of theoretical concerns about hydroquinone with continuous use. FemiCore is designed for daily use over months. The amount in a proprietary blend is probably small, but the manufacturer does not say, and this is the ingredient we would most like a number for.

Mimosa Pudica

Grade D (Weak). The “sensitive plant” is used in Ayurvedic practice for a range of complaints, including urinary ones, and laboratory and animal studies report astringent, anti-inflammatory and antimicrobial properties. We could find no human trial of mimosa pudica for any bladder outcome. Its inclusion rests on tradition and preclinical data.

Granular Berberine

Grade A for blood sugar; D for bladder. Berberine is the odd one out in this formula. It has strong human evidence, including randomised trials and meta-analyses, for lowering blood glucose and HbA1c in people with type 2 diabetes at 1,000 to 1,500 mg per day (Yin et al., 2008). It also shifts the gut microbiome in ways associated with better metabolic health.

None of that is bladder evidence. FemiCore includes berberine to support the gut environment from which urinary bacteria originate, which is an inference rather than a finding. And the doses that produce berberine’s known effects, 500 mg three times a day, could not possibly fit inside a single capsule alongside eight other ingredients. Whatever amount is present, it is far below the studied range. Berberine’s drug interactions still apply at any dose, which we cover below.

Lactobacillus acidophilus, L. plantarum, L. gasseri, L. casei

Grade C (Limited), as a group. These four are well-characterised probiotic species with research on gut health, vaginal flora balance (particularly L. gasseri and L. acidophilus) and immune signalling. They are sensible companions to L. crispatus and are found in many women’s probiotics. What is missing is any trial of these species, alone or together, for urgency or incontinence. Also missing is a CFU count: a probiotic’s effect depends on how many live organisms reach the gut, and FemiCore does not state the number per capsule, which for a probiotic product is the single most important figure on a label.

Summary table

Ingredient	Role in formula	Best human evidence	Grade
L. crispatus	Restore Lactobacillus dominance	Phase 2 RCT, vaginal, UTI recurrence	B
Cranberry extract	Urinary tract comfort	Cochrane 2023, UTI prevention	B (UTI) / D (leaks)
Bearberry leaf	Urinary cleansing	ATAFUTI RCT, no symptom benefit	C
Mimosa pudica	Calm bladder wall	Preclinical only	D
Berberine	Gut environment	Strong for glucose, none for bladder	D (bladder)
L. acidophilus	Lactic acid, gut and vaginal flora	General probiotic data	C
L. plantarum	Gut barrier	General probiotic data	C
L. gasseri	Urogenital flora	Vaginal flora studies	C
L. casei	Digestion, immune signalling	General probiotic data	C

The proprietary blend problem

This is the section that decides the overall grade.

FemiCore lists all nine ingredients under a single proprietary blend. The total weight of the blend is the only figure available. United States labelling rules allow this: ingredients inside a blend must be listed in descending order of weight, but individual amounts can be withheld. The practical effect is that a buyer cannot tell whether the cranberry is 500 mg or 50 mg, whether the probiotics total 10 billion CFU or 100 million, or whether the bearberry is present at a level that matters for the safety guidance above.

For a product whose entire case rests on delivering live Lactobacillus to a specific place in the body, the missing CFU count is a serious omission. Reputable probiotic manufacturers state CFU at the time of expiry, name the specific strains (for example L. crispatus CTV-05, the strain in the Stapleton trial) and explain how the capsule protects the bacteria through stomach acid. FemiCore does none of these.

To be fair to the product, it does not make quantitative claims either. It does not say “36 mg of PACs” or “10 billion CFU” and then fail to deliver. It simply gives you no numbers. That is more honest than mislabelling, and less useful than transparency.

How FemiCore is meant to work, week by week

The manufacturer’s directions are one capsule each morning with a full glass of water. There is no loading phase and no need to take it with food, although taking probiotics with a meal generally improves survival through the stomach.

Based on the mechanism and on the pattern in customer feedback, a realistic expectation looks like this:

• Weeks 1 to 2. Nothing noticeable in the bladder. Some women report mild bloating or looser stools as the probiotic strains establish. This usually settles.
• Weeks 3 to 4. The first change most customers mention is fewer night-time trips. If the urinary tract was mildly irritated, cranberry and bearberry may be contributing here.
• Weeks 6 to 8. Urgency episodes reportedly become less frequent and less intense. This is the window the 60-day guarantee covers, so it is the point to decide whether to continue.
• Weeks 8 to 12. The manufacturer’s stated target for microbiome rebalancing. Feedback from women who report the largest changes usually describes this point.

If you have had no change at all by week six, the honest reading is that FemiCore is unlikely to start working at week ten. Use the guarantee.

Side effects, interactions and who should not take it

FemiCore has no stimulants, no caffeine and no hormones, and the majority of users report no side effects. The ingredients still carry specific cautions.

Probiotic adjustment. Bloating, gas or a change in stool consistency in the first week is common with any Lactobacillus product and usually resolves. People who are severely immunocompromised should discuss any live-bacteria supplement with their physician.

Berberine. Even at an undisclosed, probably small dose, berberine inhibits the liver enzymes CYP3A4, CYP2D6 and CYP2C9 and the transporter P-glycoprotein. It can raise blood levels of drugs cleared by those pathways, including cyclosporine, some statins, some calcium-channel blockers and tacrolimus. It also lowers blood sugar, which adds to insulin and sulfonylureas. Anyone on regular prescription medication should run FemiCore past a pharmacist.

Bearberry. Not recommended for long-term continuous use in European herbal monographs, not recommended in pregnancy, breastfeeding, kidney disease or for children. Arbutin works best in alkaline urine, so acidic foods and vitamin C in large amounts may reduce its effect, for what that is worth at an unknown dose.

Cranberry. Generally safe. Large amounts can interact with warfarin and may increase kidney stone risk in people prone to oxalate stones.

Pregnancy and breastfeeding. Not recommended, chiefly because of berberine, which can cause dangerous jaundice in newborns, and bearberry.

Symptoms that need a doctor, not a capsule. Pain or burning on urination, blood in the urine, fever, sudden new incontinence, incontinence after a fall or back injury, or a feeling of something bulging in the vagina. These point to infection, prolapse or a neurological cause, none of which a supplement addresses.

Pricing, cost per day and the guarantee

Prices below are taken from the official website at the time of writing. The manufacturer sets them and may change them.

Package	Price per bottle	Shipping	Total	Cost per day	Extras
2 bottles (60 days)	$79	$9.99	$167.99	$2.80	None
3 bottles (90 days)	$69	Free (US)	$207	$2.30	None
6 bottles (180 days)	$49	Free (US)	$294	$1.63	3 digital bonus guides

Three things stand out.

First, the 2-bottle package is poor value: it is the only one with a shipping charge and it costs 72 percent more per day than the 6-bottle package. Second, since the manufacturer’s own guidance is 60 to 90 days, the 3-bottle package is the logical minimum for a fair trial. Third, the 6-bottle package costs less per bottle than most single-ingredient women’s probiotics from reputable brands, which typically sell at $30 to $45 for a 30-day supply. Whether that comparison favours FemiCore depends entirely on the undisclosed CFU count.

Bonuses. The 6-bottle order includes three digital guides the manufacturer values at $793 in total: 7 Days to Rekindle the Passion in Your Marriage ($199), Reset Your Gut ($397) and Unlock Painless Hips and Legs ($197). Treat the listed values as marketing. The gut guide is at least on-topic for a probiotic product; the others are standard bonus material and should not influence the decision.

Guarantee. Sixty days from purchase, on every package. To claim it you contact support, return all bottles whether empty or full, and include the packing slip. Return postage is your cost, and the $9.99 shipping on the 2-bottle package may not be refunded. The requirement to return bottles is standard for this retailer; it is a real guarantee but not a no-questions-asked one, so keep the packaging.

FemiCore compared with the alternatives

A fair review has to ask what else the same money, or less, could do.

Pelvic floor muscle training. This is the first-line treatment for stress and mixed incontinence, and it is free. A Cochrane review of 31 trials found that women who did supervised pelvic floor training were about eight times more likely to report cure of stress incontinence than women who did not, with improvements in leak frequency and quality of life (Dumoulin et al., 2018). If your leaks happen when you cough, sneeze, laugh or lift, start here, with or without FemiCore. The microbiome theory applies mainly to urgency, not stress leaks.

A standalone women’s probiotic with a named strain and CFU count. Several reputable brands sell L. crispatus or L. rhamnosus GR-1 / L. reuteri RC-14 products with stated CFU, strain identifiers and third-party testing, usually for $30 to $45 a month. You lose the botanicals and gain transparency. For a reader whose priority is knowing what they are taking, this is the better-documented route.

Cranberry PAC extract. If recurrent urinary tract infections are part of the picture, a cranberry extract standardised to 36 mg PACs per day is the evidence-based choice and costs $10 to $20 a month.

Prescription options. Anticholinergics (oxybutynin, solifenacin) and the beta-3 agonist mirabegron reduce urgency in trials but carry side effects, from dry mouth and constipation to, for the older anticholinergics, concerns about cognitive effects with long-term use. They require a diagnosis, which is itself valuable: a clinician can rule out infection, check for prolapse and assess the pelvic floor.

Where does FemiCore fit? It is a convenience product: a single capsule that bundles a probiotic strategy with the two most relevant urinary botanicals, at a price that is reasonable if the doses are meaningful and poor if they are not. It suits a woman with mild to moderate urgency who has already been checked by a doctor, is doing pelvic floor work, and wants to test the microbiome approach over a guaranteed window.

Pros and cons

What FemiCore gets right

• The formula follows a genuine line of research on the bladder microbiome rather than a marketing invention.
• L. crispatus and cranberry are the two ingredients a urologist would expect to see, and both have randomised trial evidence for urinary outcomes.
• One capsule a day, no stimulants, no hormones, nothing that interferes with sleep.
• Manufactured under GMP in an FDA-registered facility, with non-GMO sourcing.
• A 60-day guarantee that covers the realistic trial period.
• The 6-bottle price undercuts many single-strain probiotics.

What holds it back

• Every dose is hidden inside a proprietary blend. No CFU count, no PAC content, no bearberry amount.
• No ingredient, and not the product, has been tested for leaks or urgency in a trial.
• The L. crispatus evidence comes from a vaginal product, not an oral capsule, and the strain is not named.
• Bearberry is a short-course herb in European guidance and is here in a daily, months-long product.
• Berberine brings drug interactions without bringing any bladder evidence.
• The guarantee requires returning bottles at your cost; it is fair but not frictionless.
• The 19,263-review figure and 4.8 rating are the manufacturer’s own numbers and cannot be verified independently.

Verdict

FemiCore is better thought out than most supplements sold for bladder leaks. The science it cites is real, the two headline ingredients have credible trials for urinary health, and the product is sold with a guarantee long enough to actually test it. If the manufacturer published the amounts, and especially the probiotic CFU count and strain identifiers, this would be a B-grade product and an easy recommendation for women with urgency symptoms.

It did not, so it is not. Evidence grade C (Limited). The honest summary is this: FemiCore is a plausible, low-risk trial for a woman with mild urgency or leaks who has been checked by a clinician, is doing pelvic floor training, and wants a once-daily probiotic-and-botanical approach with a refund window. It is not a treatment for infection, prolapse, stress incontinence or nerve-related bladder problems, and it should not be started by anyone on interacting medication, or during pregnancy, without medical advice.

If you decide to try it, buy the 3- or 6-bottle package so that the trial covers the 60- to 90-day window, keep the bottles and packing slip, and judge it honestly at day 60. If night-time trips and urgency have not changed by then, claim the refund and put the money towards a named-strain probiotic or a pelvic floor physiotherapy session instead.